Table 1.
Patient characteristics
| n=139 | |
|---|---|
| Age, years, median (IQR) | 65 (56–71) |
| Gender, n (%) | |
| Male | 99 (71) |
| Female | 40 (29) |
| Body mass index, median (IQR) | 27.7 (24.9–30.6) |
| Age-adjusted Charlson score, n (%) | |
| 0 | 11 (8) |
| 1 | 28 (20) |
| 2 | 33 (24) |
| 3 | 38 (27) |
| 4 | 17 (12) |
| 5+ | 12 (9) |
| Clinical T stage, n (%) | |
| T2 | 84 (60) |
| T3 | 41 (29) |
| T4 | 14 (10) |
| Pathologic T stagea, n (%) | |
| pT0 | 24 (17) |
| pTis | 22 (16) |
| pT1 | 11 (8) |
| pT2 | 17 (12) |
| pT3 | 57 (41) |
| pT4 | 8 (6) |
| Pathologic N stage, n (%) | |
| pN0 | 99 (71) |
| pN+ | 37 (27) |
| pNx | 3 (2) |
| Smoking status, n (%) | |
| Never | 35 (25) |
| Former | 63 (45) |
| Activeb | 41 (29) |
| Packs per day, median (IQR) | 1.0 (0.0–1.5) |
| Pack-years, median (IQR) | 20.0 (0.0–45.0) |
a
Four patients <pT2 were also node-positive at cystectomy
b
Any reported smoking history within one year of initial diagnosis